Host variations in SARS-CoV-2 infection
buir.contributor.author | Çetin, Güneysu | |
buir.contributor.orcid | Çetin, Güneysu|0000-0002-3464-8695 | |
dc.citation.epage | 424 | en_US |
dc.citation.spage | 404 | en_US |
dc.contributor.author | Savcı, E. Z. | |
dc.contributor.author | Özkara, B. | |
dc.contributor.author | Alkan, K. | |
dc.contributor.author | Namdar, D. S. | |
dc.contributor.author | Tunçer, G. | |
dc.contributor.author | Kılınç, B. R. | |
dc.contributor.author | Suiçmez, E. | |
dc.contributor.author | Ünal, S. | |
dc.contributor.author | Dönmüş, B. | |
dc.contributor.author | Karagülleoğlu, Z. Y. | |
dc.contributor.author | Uncuoğlu, D. B. | |
dc.contributor.author | Tekeli, C. | |
dc.contributor.author | Mendi, A. H. | |
dc.contributor.author | Bengi, V. U. | |
dc.contributor.author | Seval, G. C. | |
dc.contributor.author | Kılıç, P. | |
dc.contributor.author | Altuntaş, E. G. | |
dc.contributor.author | Dora, D. D. | |
dc.contributor.author | Çetin, Güneysu | |
dc.contributor.author | Altıok, D. | |
dc.date.accessioned | 2022-02-10T12:54:13Z | |
dc.date.available | 2022-02-10T12:54:13Z | |
dc.date.issued | 2021-08-30 | |
dc.department | Department of Molecular Biology and Genetics | en_US |
dc.description.abstract | The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the zoonotic pathogen that causes the “Coronavirus Disease of 2019 (COVID-19)”, and COVID-19 itself is yet to be thoroughly understood. Both the disease as well as the mechanisms by which the host interacts with the SARS-CoV-2 have not been fully enlightened. The epidemiological factors –e.g. age, sex, race-, the polymorphisms of the host proteins, the blood types and individual differences have all been in discussions about affecting the progression and the course of COVID-19 both individually and collectively, as their effects are mostly interwoven. We focused mainly on the effect of polymorphic variants of the host proteins that have been shown to take part in and/or affect the pathogenesis of COVID-19. Additionally, how the procedures of diagnosing and treating COVID-19 are affected by these variants and what possible changes can be implemented are the other questions, which are sought to be answered. | en_US |
dc.identifier.doi | 10.3906/biy-2104-67 | en_US |
dc.identifier.eissn | 1303-6092 | |
dc.identifier.issn | 1300-0152 | |
dc.identifier.uri | http://hdl.handle.net/11693/77241 | |
dc.language.iso | English | en_US |
dc.publisher | TÜBİTAK | en_US |
dc.relation.isversionof | https://doi.org/10.3906/biy-2104-67 | en_US |
dc.source.title | Turkish Journal of Biology | en_US |
dc.subject | Angiotensin-converting enzyme 2 (ACE2) | en_US |
dc.subject | Transmembrane serine protease 2 (tmprss2) | en_US |
dc.subject | Host genetics | en_US |
dc.subject | Polymorphisms | en_US |
dc.subject | Sars-cov-2 | en_US |
dc.subject | Toll-like receptors (tlr) | en_US |
dc.title | Host variations in SARS-CoV-2 infection | en_US |
dc.type | Review | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Host_variations_in_SARS-CoV-2_infection.pdf
- Size:
- 1.72 MB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.69 KB
- Format:
- Item-specific license agreed upon to submission
- Description: